发明名称 Targeted protein replacement for the treatment of lysosomal storage disorders
摘要 The present invention relates to compositions and methods for delivering lysosomal proteins. The compositions and methods described herein permit the targeted delivery of exogenous lysosomal proteins to cell surface proteins that allow their internalization via non-clathrin pathways. The present invention further relates to the use of the compositions and methods for enzyme replacement therapy of lysosomal storage diseases. Nucleic acids, recombinant cells and kits useful for making and using the compositions of the invention are also provided.
申请公布号 US8889127(B2) 申请公布日期 2014.11.18
申请号 US200511631248 申请日期 2005.07.01
申请人 Icahn School of Medicine at Mount Sinai 发明人 Muro Galindo Silvia;Muzykantov Vladimir R.;Schuchman Edward Howard
分类号 A61K38/46;A61K39/00;B32B5/16;C12N9/96;C12N9/14;C07H21/04;A61K47/48;C12N9/16;A61K38/00 主分类号 A61K38/46
代理机构 Jones Day 代理人 Jones Day
主权项 1. A composition comprising a mammalian acid sphingomyelinase or an active fragment thereof which is attached to a targeting moiety, wherein the targeting moiety binds to an extracellular portion of Intercellular Adhesion Molecule-1 (ICAM-1) or Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1).
地址 New York NY US
您可能感兴趣的专利